NCT00154050View on ClinicalTrials.gov

High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent Angioplasty

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

July 31, 2006

Conditions
Arterial Occlusive Diseases
Interventions
DRUG

candesartan (drug) or quinapril (drug)

Trial Locations (1)

09313

Chemnitz Hospital, Dept. of Internal Medicine I, Chemnitz

All Listed Sponsors
lead

Technische Universität Dresden

OTHER

NCT00154050 - High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent Angioplasty | Biotech Hunter | Biotech Hunter